Bristol-Myers Squibb-CVRPreferred / convertible
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Bristol-Myers Squibb-CVR in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Beddow Capital Management Inc. ($0).
- Company
- Bristol-Myers Squibb-CVR
- CUSIP
- 110122157
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,250 shares sold, net −1,250 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Beddow Capital Management Inc. | — | Reduce -0.2% | 552,539 | $0 |
"% of holder's portfolio" is BRISTOL-MYERS SQUIBB-CVR's weight in each manager's 13F, not the share of Bristol-Myers Squibb-CVR the manager owns.